RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. coparion
C

coparion portfolio

coparion has 2 portfolio companies on record at Recent Funding. Its most recent investment on record is Tubulis's $138M Series B+ round in March 2024, alongside Seventure Partners, OCCIDENT, Nextech Invest and 6 others. By category, its portfolio leans toward Health and bio (2) and Logistics and mobility (1). It has co-invested with HTGF, Seventure Partners and OCCIDENT, most often HTGF (3 rounds).

Type: Investor.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 0.
Capital in their rounds: $322.04M.
Latest deal: Tubulis · Mar 14, 2024.

What coparion invests in

coparion recent investments

CompanyRoundDateAlongside
TTubulisSeries B+ · $138MSeventure Partners, OCCIDENT, Nextech Invest (lead) +6
CCatalYmSeries B+ · $50MVesalius Biocapital Partners, Novartis Venture Fund, Jeito Capital (lead) +4
TTubulisSeries B+ · $63MSeventure Partners, OCCIDENT, HTGF +5
CCatalYmSeries B+ · $59.04MWachstumsfonds Bayern, Vesalius Biocapital Partners (lead), Novartis Venture Fund +2
TTubulisSeries A · $12MSeventure Partners, OCCIDENT, HTGF (lead) +2

How coparion invests

StageDealsCapital in rounds
Series B+ 4 80%$310.04M
Series A 1 20%$12M
YearDealsCapital in rounds
2020 2 40%$71.04M
2022 2 40%$113M
2024 1 20%$138M

Share is of the 5 rounds on Recent Funding that name coparion. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

coparion portfolio companies

CompanyRound with coparionTotal raisedLatest raise
TTubulis
Health and bio
Series B+ · $138M$573MOct 16, 2025
Series B+
CCatalYm
Health and bio
Series B+ · $50M$259.04MJul 16, 2024
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists coparion, which is a subset of its real portfolio. API: /api/v1/investors/coparion (get a free API key). More: the most active VC firms and new venture capital funds.